BACKGROUND: It is unknown whether progression of familial idiopathic dilated cardiomyopathy differs from progression in the non-familial form. It has been suggested that familial disease indicates a worse prognosis, and that this should be considered when planning the timing of heart transplantation. OBJECTIVE: To compare five year survival or time to heart transplantation in an unselected series of patients with dilated cardiomyopathy who had been evaluated for familial v non-familial disease through the echocardiographic investigation of first degree relatives. DESIGN: Medical records were reviewed and questionnaires were mailed to all patients who had previously participated in a family based study of dilated cardiomyopathy. Information was gathered about survival, heart transplantation, and left ventricular ejection fraction (LVEF) measurements. Survival data were censored at the time of cardiac transplantation. RESULTS: Follow up data were obtained for 99 of 101 patients (69 with non-familial and 30 with familial disease). Five year survival was 55% for non-familial and 51% for familial patients (NS). The main predictor of mortality was an LVEF of < 30%. Familial status did not predict mortality. There was no significant difference in follow up LVEF values between the groups. CONCLUSIONS: Five year survival is not significantly different in the familial and non-familial forms of dilated cardiomyopathy.
BACKGROUND: It is unknown whether progression of familial idiopathic dilated cardiomyopathy differs from progression in the non-familial form. It has been suggested that familial disease indicates a worse prognosis, and that this should be considered when planning the timing of heart transplantation. OBJECTIVE: To compare five year survival or time to heart transplantation in an unselected series of patients with dilated cardiomyopathy who had been evaluated for familial v non-familial disease through the echocardiographic investigation of first degree relatives. DESIGN: Medical records were reviewed and questionnaires were mailed to all patients who had previously participated in a family based study of dilated cardiomyopathy. Information was gathered about survival, heart transplantation, and left ventricular ejection fraction (LVEF) measurements. Survival data were censored at the time of cardiac transplantation. RESULTS: Follow up data were obtained for 99 of 101 patients (69 with non-familial and 30 with familial disease). Five year survival was 55% for non-familial and 51% for familial patients (NS). The main predictor of mortality was an LVEF of < 30%. Familial status did not predict mortality. There was no significant difference in follow up LVEF values between the groups. CONCLUSIONS: Five year survival is not significantly different in the familial and non-familial forms of dilated cardiomyopathy.
Authors: M Kamisago; S D Sharma; S R DePalma; S Solomon; P Sharma; B McDonough; L Smoot; M P Mullen; P K Woolf; E D Wigle; J G Seidman; C E Seidman Journal: N Engl J Med Date: 2000-12-07 Impact factor: 91.245
Authors: D Fatkin; C MacRae; T Sasaki; M R Wolff; M Porcu; M Frenneaux; J Atherton; H J Vidaillet; S Spudich; U De Girolami; J G Seidman; C Seidman; F Muntoni; G Müehle; W Johnson; B McDonough Journal: N Engl J Med Date: 1999-12-02 Impact factor: 91.245
Authors: S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin Journal: J Clin Invest Date: 2000-09 Impact factor: 14.808
Authors: J B Goerss; V V Michels; J Burnett; D J Driscoll; F Miller; R Rodeheffer; A J Tajik; D Schaid Journal: Eur Heart J Date: 1995-12 Impact factor: 29.983
Authors: Marwan M Refaat; Steven A Lubitz; Seiko Makino; Zahid Islam; J Michael Frangiskakis; Haider Mehdi; Rebecca Gutmann; Michael L Zhang; Heather L Bloom; Calum A MacRae; Samuel C Dudley; Alaa A Shalaby; Raul Weiss; Dennis M McNamara; Barry London; Patrick T Ellinor Journal: Heart Rhythm Date: 2011-10-17 Impact factor: 6.343
Authors: Christine S Zuern; Britta Walker; Martina Sauter; Malte Schaub; Madhumita Chatterjee; Karin Mueller; Dominik Rath; Sebastian Vogel; Roland Tegtmeyer; Peter Seizer; Tobias Geisler; Reinhard Kandolf; Florian Lang; Karin Klingel; Meinrad Gawaz; Oliver Borst Journal: Clin Res Cardiol Date: 2015-05-26 Impact factor: 5.460
Authors: Nisha Arenja; Johannes H Riffel; Manuel Halder; Charly N Djiokou; Thomas Fritz; Florian Andre; Fabian Aus dem Siepen; Thomas Zelniker; Benjamin Meder; Elham Kayvanpour; Grigorios Korosoglou; Hugo A Katus; Sebastian J Buss Journal: Eur Radiol Date: 2017-02-10 Impact factor: 5.315
Authors: Sara B Seidelmann; Olga Laur; John Hwa; Eugene Depasquale; Lavanya Bellumkonda; Lissa Sugeng; Pawel Pomianowski; Jeffrey Testani; Michael Chen; William McKenna; Daniel Jacoby Journal: J Heart Lung Transplant Date: 2015-12-11 Impact factor: 10.247
Authors: Karin A L Müller; Iris Müller; Ulrich Kramer; Reinhard Kandolf; Meinrad Gawaz; Axel Bauer; Christine S Zuern Journal: PLoS One Date: 2013-02-20 Impact factor: 3.240
Authors: Johannes H Riffel; Marius G P Keller; Franziska Rost; Nisha Arenja; Florian Andre; Fabian Aus dem Siepen; Thomas Fritz; Philipp Ehlermann; Tobias Taeger; Lutz Frankenstein; Benjamin Meder; Hugo A Katus; Sebastian J Buss Journal: J Cardiovasc Magn Reson Date: 2016-06-07 Impact factor: 5.364